Manish Jha

Assistant Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Manish Jha is an Assistant Professor at The University of Texas Southwestern Medical Center Medical School in the United States. His research primarily focuses on depression, the pharmacologic management of treatment-resistant depression, and the use of brain and blood biomarkers for antidepressant selection. He has contributed to recent studies on practical clinical applications and the effects of various treatment methods for major depressive disorder and methamphetamine use disorder.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Sara Costi

University of Oxford

UNITED KINGDOM

View details

William Bobo

Florida State University

UNITED STATES

View details

Spencer Evans

Assistant Professor

University of Miami

UNITED STATES

View details

Russell Toll

Assistant Professor

UNITED STATES

View details

William McCall

Augusta University

UNITED STATES

View details

Madhukar H. Trivedi

UNITED STATES

View details

Julia Linke

Professor Clinical Psychology and Psychotherapy for Children and Adolescents

University of Freiburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manish Jha

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Towards causal inference-based antidepressant selection with brain and blood biomarkers

Cross-Cultural Consortium on Irritability (C3I): An International Network for Research on Cultural Similarities and Differences in Irritability

A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study.

Association between anhedonia severity and clinical, humanistic, and economic outcomes among US adults with major depressive disorder.

Baseline Moderators of Response to Naltrexone and Bupropion in the Treatment of Methamphetamine Use Disorder: An ADAPT-2 Study.

Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language models.

Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial.

Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial.

Building Competency in Administering Intravenous Racemic Ketamine: A Single Site Experience of Expanding Residency Education in Interventional Psychiatry.

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.

Predicting suicidal events: A comparison of the Concise Health Risk Tracking Self-Report (CHRT-SR) and the Columbia Suicide Severity Rating Scale (C-SSRS).

Psychosocial stress and well-being in patients presenting with acute myocardial infarction in a tertiary care center.

The Individual and Societal Burden of Treatment-Resistant Depression: An Overview.

Treatment-Resistant Depression (TRD): Management Approaches in a Rapidly Evolving Therapeutic Landscape.

Association of Depression and Cardiovascular Disease.

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report.

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study.

Collaborators (7)

Sara Costi

William Bobo

Spencer Evans

Russell Toll

William McCall

Madhukar H. Trivedi

Julia Linke

Make your next move.